Condition: Acute Pain · Anesthesia · Lumbar Spine Disease · Sponsor: Pontificia Universidad Catolica de Chile
This randomized, blinded, controlled clinical trial aims to evaluate the effectiveness of ultrasound-guided retrolaminar block in reducing postoperative opioid consumption in patients undergoing lumbar spine fusion surgery under multimodal analgesia. The participants will: * Be randomly assigned in a 1:1 ratio to receive either a retrolaminar block with 0.25% bupivacaine plus epinephrine or a sham block (normal saline) prior to surgical incision. * Receive standardized multimodal analgesia. * Have follow-up by the Acute Pain Unit during the first 3 days, to assess opioid consumption (morphine) in 24 hours, pain intensity measured by Numeric Rating Scale, quality of recovery assessed by the QoR-15 questionnaire, intraoperative blood loss, and postoperative complications.
This description comes directly from the study's public registry record.
Juan Carlos De la Cuadra-Fontaine, MD · 5695337297 · juancarl@ucchristus.cl
Victor Contreras, MSN · 56223543414 · vecontre@uc.cl
Always discuss trial participation with your own doctor first.
| Hospital Clínico Pontificia Universidad Católica de Chile | Santiago, Santiago Metropolitan, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07291388